Parametric Portfolio Associates LLC grew its position in Chemed Corp. (NYSE:CHE) by 5.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 70,537 shares of the company’s stock after acquiring an additional 3,375 shares during the quarter. Parametric Portfolio Associates LLC owned approximately 0.44% of Chemed Corp. worth $14,427,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. increased its holdings in shares of Chemed Corp. by 145,760.9% in the 1st quarter. BlackRock Inc. now owns 1,955,994 shares of the company’s stock valued at $357,341,000 after acquiring an additional 1,954,653 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Chemed Corp. by 1.9% in the 2nd quarter. Vanguard Group Inc. now owns 1,830,711 shares of the company’s stock valued at $374,435,000 after acquiring an additional 34,938 shares during the last quarter. Acadian Asset Management LLC increased its holdings in shares of Chemed Corp. by 1.3% in the 2nd quarter. Acadian Asset Management LLC now owns 579,170 shares of the company’s stock valued at $118,454,000 after acquiring an additional 7,636 shares during the last quarter. State Street Corp increased its holdings in shares of Chemed Corp. by 9.1% in the 1st quarter. State Street Corp now owns 445,367 shares of the company’s stock valued at $81,370,000 after acquiring an additional 37,085 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of Chemed Corp. by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 393,983 shares of the company’s stock valued at $71,979,000 after acquiring an additional 1,695 shares during the last quarter. Institutional investors and hedge funds own 96.96% of the company’s stock.

Shares of Chemed Corp. (NYSE CHE) opened at 203.52 on Friday. Chemed Corp. has a one year low of $132.92 and a one year high of $216.01. The company has a market capitalization of $3.25 billion, a P/E ratio of 50.49 and a beta of 1.13. The stock has a 50 day moving average price of $194.81 and a 200-day moving average price of $197.29.

Chemed Corp. (NYSE:CHE) last announced its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, topping the Zacks’ consensus estimate of $1.89 by $0.26. Chemed Corp. had a return on equity of 26.18% and a net margin of 4.16%. The company had revenue of $415.06 million during the quarter, compared to the consensus estimate of $407.56 million. During the same quarter last year, the company earned $1.80 EPS. The company’s quarterly revenue was up 6.3% on a year-over-year basis. Equities research analysts predict that Chemed Corp. will post $8.21 earnings per share for the current fiscal year.

In other Chemed Corp. news, insider Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $197.46, for a total value of $197,460.00. Following the completion of the sale, the insider now owns 37,809 shares in the company, valued at approximately $7,465,765.14. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Patrick P. Grace sold 500 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $201.48, for a total value of $100,740.00. Following the completion of the sale, the director now owns 4,515 shares of the company’s stock, valued at approximately $909,682.20. The disclosure for this sale can be found here. Insiders sold a total of 16,500 shares of company stock valued at $3,315,600 in the last quarter. Corporate insiders own 5.32% of the company’s stock.

A number of brokerages have recently weighed in on CHE. Royal Bank Of Canada reiterated a “hold” rating and issued a $209.00 price target on shares of Chemed Corp. in a report on Tuesday, October 3rd. Zacks Investment Research downgraded Chemed Corp. from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. BidaskClub downgraded Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. KeyCorp began coverage on Chemed Corp. in a report on Monday, August 28th. They issued a “sector weight” rating for the company. Finally, TheStreet downgraded Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Three equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Chemed Corp. has a consensus rating of “Hold” and an average price target of $215.00.

ILLEGAL ACTIVITY NOTICE: “Chemed Corp. (CHE) Shares Bought by Parametric Portfolio Associates LLC” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international trademark and copyright law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/08/chemed-corp-che-shares-bought-by-parametric-portfolio-associates-llc.html.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)

Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.